Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The synaptophysin-like 1 pseudogene (ENSG00000270890) is a non-coding genomic sequence similar in arrangement and sequence to the functional Synaptophysin-like 1 (SYPL1) gene but contains mutations, deletions, or other disablements that prevent it from being expressed as a protein-coding gene. Pseudogenes such as this one can occasionally be transcribed into RNA, but do not normally produce functional protein. Their biological relevance is generally minimal, although rare exceptions exist in which pseudogenes can influence gene regulation via various mechanisms. The SYPL1 gene itself encodes a protein involved in synaptic transmission and vesicle trafficking, but the pseudogene version does not share these functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptophysin-like 1 pseudogene (SYPL1 pseudogene).